Search Results
145 items found for "British Pharmacological Society"
- Ep 58 with Dr. Juan José Fung
mainly focused on screening and assay development to bridge the gap between in vitro and in vivo GPCR pharmacology
- Ep 28 with Dr. Ross Cheloha
Work in his independent laboratory is focused on developing new pharmacological tools via chemistry and
- Ep 111 with Chloe Hicks
will graduate from Duke University this spring with a B.S degree in Biology with a concentration in Pharmacology
- Ep 138 with Dr. Daniel Isom
Isom was recruited to the Molecular and Cellular Pharmacology Department at the University of Miami Miller
- Ep 01 with Dr. Paul Insel
on, Paul was hooked and has since studied receptor function in human physiology, receptor molecular pharmacology
- Ep 39 with Dr. Kathryn E Livingston
Kathryn obtained her BS in Chemistry from Carnegie Mellon University and went on to receive a Ph.D. in Pharmacology
- Ep 110 with Dr. G. Aditya Kumar
In his (future) independent research career, Aditya aims to work at the interface of GPCR molecular pharmacology
- Ep 151 with Dr GPCR Board
Trejo joined the faculty in the Department of Pharmacology at the University of North Carolina in 2000 and then moved to UC San Diego School Medicine, Department of Pharmacology in 2008, where she quickly In 2014, she was appointed Vice-Chair of the Department of Pharmacology. The long-term goal of Dr.
- Ep 108 with Dr. Kenneth A. Jacobson
He adapts interdisciplinary approaches (synthesis, modeling, pharmacology) to study G protein-coupled
- Cannabinoid compounds to augment L-DOPA treatment in Parkinson's Disease
In April 2009, he joined the Department of Pharmacology and Toxicology at University of Toronto and has
- G Proteins and GPCRs in Cancer: Novel Precision Targeted and Immunotherapies
Gutkind is a Distinguished Professor and Chair of the Department of Pharmacology, School of Medicine,
- Ep 74 with Dr. Daniel Wacker
Bryan Roth where I established GPCR structural biology and learned the ins and outs of molecular pharmacology
- Ep 61 with About Dr. Marta Filizola
Kase, MD Professor in the Departments of Pharmacological Sciences, Neuroscience, and Artificial Intelligence
- Ep 59 with Dr. Nicola J. Smith
Nicola J Smith is an expert in molecular pharmacology with a track record in exploring GPCR structure-function
- Abstract Submission Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Disease Immunology Nervous system Model Organism Phylogenetics and Evolution Aging Basic and Clinical Pharmacology
- GPCR Retreat Logo Contest | Dr. GPCR Ecosystem
material that reflects the diverse fields of study encompassing GPCR research, such as biochemistry, pharmacology
- Emerging GPCR targets for AUD: Insights from preclinical studies
Specifically, we focus on preclinical evidence of compounds with attractive pharmacological profiles
- Session VII | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Knowledge of the structural dynamics of this complex is limited and pharmacological and in vivo systems characterizing newly generated adhesion GPCR receptors in Drosophila as a model organism for future pharmacological
- Ep 18 with Dr. Yamina Berchiche
The explosion of biomedical data such as in genomics, structural biology, and pharmacology can provide
- Ep 33 with Dr. David E. Gloriam
Gloriam is a corresponding member of the Nomenclature Committee of the International Union of Pharmacology
- Illuminating Functional Selectivity and Allosterism at GPCRs.
His expertise is in molecular pharmacology and his research program focuses on the molecular and cellular
- Chemokine N-terminal-derived peptides differentially regulate signaling by the receptors CCR1 and CCR5
Proost , Mette M Rosenkilde Tags GPCR , allosteric modulation , chemokine , chemokine truncation , pharmacology
- Ep 143 with Dr Davide Calebiro
Between 2009 and 2017, he was a Group Leader at the Institute of Pharmacology and Toxicology and Rudolf
- Ep 32 with Dr. Chris Tate
Subsequent work has focused on understanding the molecular basis of GPCR pharmacology through structure
- Ep 98 with Dr. GPCR Team
As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and
- Ep 103 with Dr Kathleen Caron
Caron is also past Associate Editor at JCI and served as the inaugural Associate Editor at ACS-Pharmacology
- Chemokine Physiology in Cancer
expression of atypical receptors and non-GPCR binding partners that cumulatively influence discrete pharmacological
- GPCRs and fibroblast heterogeneity in fibroblast-associated diseases
signaling , fibroblast behavior , fibrotic diseases , functional heterogeneity , pathophysiology , pharmacological